4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000055
Chief Technology Officer acquired 76,181 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stout Jay S Chief Technology Officer | 2025-04-01 | Grant or award | +76,181 | 216,172 | D | ||
| Derivatives | |||||||
| Stout Jay S Chief Technology Officer | 2025-04-01 | Grant or award · Stock Option (right to buy) | +107,297 | 107,297 | D | ||
Loading xslF345X05/wk-form4_1743713507.xml…